Arcosa Toekomstige groei
Future criteriumcontroles 4/6
Arcosa zal naar verwachting groeien in winst en omzet met respectievelijk 35% en 11.3% per jaar. De winst per aandeel zal naar verwachting groeien met 35% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.5% zijn.
Belangrijke informatie
35.0%
Groei van de winst
35.0%
Groei van de winst per aandeel
Construction winstgroei | 26.4% |
Inkomstengroei | 11.3% |
Toekomstig rendement op eigen vermogen | 8.5% |
Dekking van analisten | Low |
Laatst bijgewerkt | 04 Nov 2024 |
Recente toekomstige groei-updates
Earnings Beat: Arcosa, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Arcosa, Inc. Just Recorded A 58% EPS Beat: Here's What Analysts Are Forecasting Next
May 05Recent updates
The Price Is Right For Arcosa, Inc. (NYSE:ACA)
Oct 24Arcosa: Still Not Cheap Enough
Oct 23Calculating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Oct 06Arcosa (NYSE:ACA) Seems To Use Debt Quite Sensibly
Sep 17Arcosa: Acquisition Of Stavola Is Expected To Strengthen Its Construction Products Segment
Aug 09Earnings Beat: Arcosa, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Arcosa, Inc.'s (NYSE:ACA) Share Price Matching Investor Opinion
Jul 16A Look At The Intrinsic Value Of Arcosa, Inc. (NYSE:ACA)
Jun 27Arcosa: Robust Infrastructure Spending And Electric Utility Transmission CAPEX
Jun 15Is Arcosa (NYSE:ACA) A Risky Investment?
Jun 09Arcosa, Inc. Just Recorded A 58% EPS Beat: Here's What Analysts Are Forecasting Next
May 05Shareholders Will Probably Not Have Any Issues With Arcosa, Inc.'s (NYSE:ACA) CEO Compensation
May 03Arcosa: Infrastructure Play Looking Sound
Apr 11What Arcosa, Inc.'s (NYSE:ACA) P/E Is Not Telling You
Apr 06Estimating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Feb 19Arcosa: A Good Business But Already Priced In
Feb 09Does Arcosa (NYSE:ACA) Have A Healthy Balance Sheet?
Feb 02Does Arcosa (NYSE:ACA) Deserve A Spot On Your Watchlist?
Jan 18Benign Growth For Arcosa, Inc. (NYSE:ACA) Underpins Its Share Price
Jan 03Calculating The Intrinsic Value Of Arcosa, Inc. (NYSE:ACA)
Nov 12Arcosa: Government Spending Is A Tailwind But Valuation Is High
Nov 03Arcosa (NYSE:ACA) Seems To Use Debt Quite Sensibly
Oct 05Do Arcosa's (NYSE:ACA) Earnings Warrant Your Attention?
Sep 14Arcosa: Some Warning Signs
Aug 10We Think Arcosa (NYSE:ACA) Can Stay On Top Of Its Debt
Jul 04Is Now The Time To Put Arcosa (NYSE:ACA) On Your Watchlist?
Jun 16We Think Arcosa (NYSE:ACA) Can Stay On Top Of Its Debt
Apr 02Here's Why We Think Arcosa (NYSE:ACA) Is Well Worth Watching
Mar 17Calculating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Mar 01Arcosa Non-GAAP EPS of $0.24 beats by $0.04, revenue of $500.3M beats by $23.65M
Feb 23Arcosa Q4 2022 Earnings Preview: Opinion Unchanged
Feb 17Does Arcosa (NYSE:ACA) Have A Healthy Balance Sheet?
Dec 29Arcosa declares $0.05 dividend, renews $50M stock buyback program
Dec 08Arcosa Should Sell Its Transportation Segment
Nov 16Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 3,178 | 262 | 139 | 411 | 3 |
12/31/2025 | 2,960 | 219 | 184 | 384 | 5 |
12/31/2024 | 2,596 | 131 | 94 | 298 | 5 |
9/30/2024 | 2,486 | 128 | 121 | 316 | N/A |
6/30/2024 | 2,437 | 147 | 16 | 225 | N/A |
3/31/2024 | 2,357 | 142 | 101 | 314 | N/A |
12/31/2023 | 2,308 | 159 | 58 | 261 | N/A |
9/30/2023 | 2,226 | 286 | -6 | 191 | N/A |
6/30/2023 | 2,238 | 282 | 36 | 218 | N/A |
3/31/2023 | 2,256 | 280 | 21 | 177 | N/A |
12/31/2022 | 2,243 | 245 | 36 | 174 | N/A |
9/30/2022 | 2,264 | 100 | 162 | 272 | N/A |
6/30/2022 | 2,220 | 91 | 130 | 227 | N/A |
3/31/2022 | 2,132 | 74 | 100 | 191 | N/A |
12/31/2021 | 2,036 | 69 | 81 | 167 | N/A |
9/30/2021 | 1,974 | 70 | 24 | 110 | N/A |
6/30/2021 | 1,904 | 78 | 111 | 191 | N/A |
3/31/2021 | 1,888 | 90 | 138 | 219 | N/A |
12/31/2020 | 1,936 | 106 | 178 | 260 | N/A |
9/30/2020 | 1,924 | 116 | 285 | 367 | N/A |
6/30/2020 | 1,879 | 118 | 248 | 338 | N/A |
3/31/2020 | 1,814 | 116 | 187 | 275 | N/A |
12/31/2019 | 1,737 | 112 | 273 | 359 | N/A |
9/30/2019 | 1,664 | 119 | 146 | 219 | N/A |
6/30/2019 | 1,598 | 90 | 91 | 154 | N/A |
3/31/2019 | 1,517 | 81 | 99 | 154 | N/A |
12/31/2018 | 1,460 | 76 | 74 | 119 | N/A |
9/30/2018 | 1,434 | 72 | 77 | 146 | N/A |
6/30/2018 | 1,421 | 89 | N/A | 174 | N/A |
3/31/2018 | 1,421 | 88 | N/A | 187 | N/A |
12/31/2017 | 1,462 | 90 | N/A | 162 | N/A |
12/31/2016 | 1,704 | 123 | N/A | 228 | N/A |
12/31/2015 | 2,140 | 135 | N/A | 293 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei ACA ( 35% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van ACA ( 35% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).
Hoge groeiwinsten: De winst van ACA zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van ACA ( 11.3% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van ACA ( 11.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen ACA zal naar verwachting over 3 jaar laag zijn ( 8.5 %).